Full text is available at the source.
Abstract
Comprehensive prescription drug monitoring program data reveals details about compounded weight-loss prescriptions, including rates of self-payment and out-of-state dispensing.
- Compounded GLP-1 medications are associated with various ingredients tailored for weight loss.
- Rates of self-payment for these prescriptions may indicate patient preferences or insurance limitations.
- Dispensing of compounded medications from out-of-state sources could suggest a broader market for these treatments.
Simplified